Therapeutic advances in vaccines and immunotherapy

Melanoma vaccines: types, new tumor targets, and promising combined immune treatments

Updated

Abstract

Melanoma vaccines may stimulate tumor-specific immune responses through the delivery of tumor-associated and personalized neoantigens.

  • Therapeutic melanoma vaccines are designed to target unique mutations in individual tumors.
  • Recent advances in vaccine engineering and tumor genomics have accelerated the development of personalized neoantigen vaccines.
  • Artificial Intelligence and Machine Learning are being integrated into neoantigen identification to enhance vaccine design.
  • Combination strategies with Immune Checkpoint Inhibitors have shown potential to improve T-cell activation and overcome immune suppression.
  • Despite promising safety and immunogenicity findings, challenges such as tumor heterogeneity and manufacturing complexity persist.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free